BridgeMD
New treatment option for Endometriosis
Official title Endometriosis Transcriptomic Cell Atlas
ClinicalTrials.gov ID: NCT06502548
What this study is testing
- What it's testing
- Endometriosis is an estrogen-dependent, chronic inflammatory gynecologic disease affecting women of reproductive age, with a therapeutic wandering of 6 to 10 years. A better understanding of the initiation phase is a major challenge to improve diagnosis and treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, women only
You may be able to join if
- Patients over 18 and under 45 years of age
- Patients with multiple endometriosis sites (superficial, deep and endometriomas) with an indication for surgery to treat disabling painful symptoms...
- Healthy patients including those operated on between the ages of 18 and 45 for tubal ligation
- Healthy patients operated on between the ages of 18 and 45 for hysterectomies for benign causes other than endometriosis or adenomyosis
- Patients operated on strictly at the time of menstruation
You likely can't join if
- Patients with endometriosis non-surgically treated
- Patients with endometriosis receiving hormonal treatment at the time of surgery or having received hormonal treatment in the 2 months prior to surgery
- Patients with adenomyosis only
- Healthy non-endometriotic patients undergoing hysterectomy for infectious or malignant causes
- Patients benefiting from a legal protection measure (guardianship, curatorship, safeguard of justice)
- Patients with positive serology for human immunodeficiency virus (HIV), human T-lymphotropic virus (HTLV), hepatitis B (HBV) and hepatitis C (HCV)
See the full eligibility criteria
- Patients over 18 and under 45 years of age
- Patients with multiple endometriosis sites (superficial, deep and endometriomas) with an indication for surgery to treat disabling painful symptoms and stage III or IV endometriosis in the context of infertility.
- Healthy patients including those operated on between the ages of 18 and 45 for tubal ligation
- Healthy patients operated on between the ages of 18 and 45 for hysterectomies for benign causes other than endometriosis or adenomyosis
- Patients operated on strictly at the time of menstruation
- Participants who have not been on hormonal treatment for 2 months
- Participant having signed the free and informed consent form
- Membership of a Social Security scheme or equivalent
- Patients with endometriosis non-surgically treated
- Patients with endometriosis receiving hormonal treatment at the time of surgery or having received hormonal treatment in the 2 months prior to surgery
- Patients with adenomyosis only
- Healthy non-endometriotic patients undergoing hysterectomy for infectious or malignant causes
- Patients benefiting from a legal protection measure (guardianship, curatorship, safeguard of justice)
- Patients with positive serology for human immunodeficiency virus (HIV), human T-lymphotropic virus (HTLV), hepatitis B (HBV) and hepatitis C (HCV)
The study team makes the final eligibility decision.
Where it's taking place
- Toulouse, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toulouse, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.